Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2019 Earnings Conference Call March 5, 2020 4:30 PM ET
Company Participants
Zack Kubow - Investor Relations, Pure Communications
Richard Miller - President and Chief Executive Officer
Leiv Lea - Chief Financial Officer
Conference Call Participants
Tony Butler - ROTH Capital Partners
Mara Goldstein - Mizuho
Jeet Mukherjee - Jefferies
Operator
Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Corvus Pharmaceuticals Fourth Quarter 2019 Business Update and Financial Results Webcast. Today's conference is being recorded. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.
It is now my pleasure to turn the call over to Zack Kubow of Pure Communications. Please go ahead, sir.
Zack Kubow
Thank you, operator, and good afternoon, everyone. Thanks for joining us for the Corvus Pharmaceuticals fourth quarter 2019 business update and financial results conference call.
On the call to discuss the results and business highlights for the fourth quarter 2019 are Richard Miller, Chief Executive Officer; Leiv Lea, Chief Financial Officer; and Mehrdad Mobasher, Chief Medical Officer. The executive team will open the call with some prepared remarks, followed by a question-and-answer period.
I would like to remind everyone that comments made by management today and answers to questions will include forward-looking statements. Forward-looking statements are based on estimates and assumptions as of today, and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by those statements, including the risks and uncertainties described in Corvus' quarterly report on Form 10-Q filed with the SEC on October 29, 2019 and other filings the company makes with the SEC from time to time. The company undertakes no obligation to publicly update or revise any forward-looking statements
- Read more current CRVS analysis and news
- View all earnings call transcripts